Literature DB >> 31116804

Treating psoriasis: patient assessment, treatment goals, and treatment options.

David M Pariser1, Leon H Kircik2, Linda F Stein Gold3.   

Abstract

New treatments have revolutionized the care of psoriasis in recent years, enabling patients and clinicians to set aggressive goals for disease clearance. This article reviews the National Psoriasis Foundation recommendations for assessing disease severity, targets for therapy, and follow-up intervals.

Entities:  

Year:  2019        PMID: 31116804

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  1 in total

1.  DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity.

Authors:  David W C Hunt; Iordanka A Ivanova; Lina Dagnino
Journal:  Tissue Barriers       Date:  2020-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.